We are live on !
Find out more
Values First Advisors Portfolio holdings
AUM
$213M
Turnover
12.31%
1-Year Est. Return
20.51%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+20.51%
3 Year Est. Return
+87.64%
5 Year Est. Return
+95.83%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$12.1M
(+7.1%)
Cap. Flow
+$761K
Cap. Flow % of AUM
Cap. Flow %
0.41%
Top 10 Holdings %
Top 10 Hldgs %
28.42%
Holding
196
New
14
Increased
88
Reduced
73
Closed
15
Avg Time Held
2.7
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rollins
ROL
|
+$1.72M |
| 2 |
Microchip Technology
MCHP
|
+$977K |
| 3 |
Gentex
GNTX
|
+$639K |
| 4 |
Cognex
CGNX
|
+$570K |
| 5 |
Chewy
CHWY
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$1.15M |
| 2 |
Medifast
MED
|
+$869K |
| 3 |
The Ensign Group
ENSG
|
+$771K |
| 4 |
Grand Canyon Education
LOPE
|
+$693K |
| 5 |
Amphenol
APH
|
+$551K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.34% |
| 2 | Technology | 16.19% |
| 3 | Healthcare | 15.61% |
| 4 | Industrials | 10.9% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.3B
| $9.31M | 5.07% |
92,624
-68
| -0.1% | -$6.82K |
2019 Q4
22 quarters
|
|
2
Vanguard Short-Term Treasury ETF
VGSH
$35.2B
| $7.5M | 4.09% |
127,642
-4,099
| -3% | -$240K |
2019 Q4
22 quarters
|
|
3
iShares 1-3 Year Treasury Bond ETF
SHY
$27.5B
| $6.61M | 3.6% |
79,788
+451
| +0.6% | +$37.2K |
2019 Q4
22 quarters
|
|
4
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.33B
| $6.22M | 3.39% |
127,765
-1,637
| -1% | -$79K |
2024 Q3
3 quarters
|
|
5
iShares 3-7 Year Treasury Bond ETF
IEI
$17B
| $5M | 2.73% |
42,020
-675
| -2% | -$79.6K |
2019 Q4
22 quarters
|
|
6
iShares 7-10 Year Treasury Bond ETF
IEF
$43.2B
| $4.97M | 2.71% |
51,944
-852
| -2% | -$80.6K |
2019 Q4
22 quarters
|
|
7
iShares Short Maturity Bond ETF
NEAR
$5.2B
| $4.2M | 2.29% |
82,268
-1,084
| -1% | -$55.1K |
2019 Q4
22 quarters
|
|
|
8
The Ensign Group
ENSG
$10.6B
| $3.2M | 1.74% |
20,715
-5,496
| -21% | -$771K |
2019 Q4
22 quarters
|
|
|
9
Microchip Technology
MCHP
$42.3B
| $2.67M | 1.45% |
37,915
+17,784
| +88% | +$977K |
2019 Q4
22 quarters
|
|
10
Monolithic Power Systems
MPWR
$64.8B
| $2.5M | 1.36% |
3,411
+386
| +13% | +$246K |
2020 Q4
18 quarters
|
|
|
VRNA
11
DELISTED
Verona Pharma
VRNA
| $2.43M | 1.32% |
25,661
+532
| +2% | +$39.4K |
2024 Q3
3 quarters
|
|
12
NNN REIT
NNN
$8B
| $2.43M | 1.32% |
56,168
-2,803
| -5% | -$116K |
2019 Q4
22 quarters
|
|
13
Emergent Biosolutions
EBS
$320M
| $2.4M | 1.31% |
376,003
+756
| +0.2% | +$4.33K |
2022 Q3
11 quarters
|
|
14
Lowe's Companies
LOW
$120B
| $2.35M | 1.28% |
10,594
+723
| +7% | +$161K |
2019 Q4
22 quarters
|
|
15
Mid-America Apartment Communities
MAA
$13.6B
| $2.25M | 1.23% |
15,226
-3,210
| -17% | -$501K |
2019 Q4
22 quarters
|
|
|
16
Amphenol
APH
$208B
| $2.18M | 1.19% |
44,204
-13,476
| -23% | -$551K |
2022 Q2
12 quarters
|
|
|
17
Cognex
CGNX
$9.8B
| $1.98M | 1.08% |
62,280
+19,897
| +47% | +$570K |
2019 Q4
22 quarters
|
|
18
Trane Technologies
TT
$91.4B
| $1.92M | 1.05% |
4,393
+270
| +7% | +$107K |
2020 Q3
19 quarters
|
|
19
EOG Resources
EOG
$81.4B
| $1.91M | 1.04% |
16,001
+2,604
| +19% | +$298K |
2021 Q3
15 quarters
|
|
20
Expeditors International
EXPD
$26.6B
| $1.88M | 1.03% |
16,483
+654
| +4% | +$73.2K |
2019 Q4
22 quarters
|
|
21
Badger Meter
BMI
$4.42B
| $1.88M | 1.02% |
7,679
-1,060
| -12% | -$240K |
2024 Q2
4 quarters
|
|
22
Bio-Techne
TECH
$11.4B
| $1.86M | 1.01% |
36,088
+8,638
| +31% | +$434K |
2019 Q4
22 quarters
|
|
23
Graco
GGG
$11.1B
| $1.85M | 1.01% |
21,465
-1,619
| -7% | -$134K |
2024 Q3
3 quarters
|
|
24
Donaldson
DCI
$9.9B
| $1.84M | 1% |
26,525
+2,021
| +8% | +$136K |
2019 Q4
22 quarters
|
|
25
Cincinnati Financial
CINF
$28.3B
| $1.82M | 0.99% |
12,223
-3,183
| -21% | -$456K |
2020 Q2
20 quarters
|
|
Similar funds
BGI
Values First Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Values First Advisors held 196 positions worth $184M, up 7.1% from $171M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Values First Advisors's Q2 2025 filing shows 14 new, 88 increased, 73 reduced and 15 closed positions. Its largest new stake was Rollins: 30,743 shares worth $1.73M. The largest sale was Alnylam Pharmaceuticals, an estimated $1.15M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 32% a quarter earlier, followed by Technology and Healthcare.
- Values First Advisors's largest Q2 2025 buy was Rollins: 30,743 shares worth $1.73M.
- Values First Advisors added most to Microchip Technology in Q2 2025, an estimated $977K increase.
- Values First Advisors's biggest Q2 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.15M.
- Values First Advisors fully exited Medifast in Q2 2025, selling an estimated $869K.
- Values First Advisors's ten largest holdings make up 28% of its $184M portfolio in Q2 2025.
- Values First Advisors opened 14 new positions and closed 15 in Q2 2025.
- Values First Advisors's portfolio value rose 7.1% quarter-over-quarter to $184M.
Based on Values First Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.